Trial NCT03850535

View at ClinicalTrials.gov 
Org. Study IDs: GO40800
Secondary IDs: 2018-002964-25

Last trial update was posted on 2022-06-21

MeSH Interventions

Cytarabine Daunorubicin

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute

Other Conditions

Acute Myeloid Leukemia

Stopping Reasons

Sponsor's decision to terminate the study after Phase 1; will not proceed with Phase 2.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID